Flatiron Health takes in $175 mln Series C
Oncology software provider Flatiron Health has raised $175 million in Series C funding. Roche led the round with participation from other investors that included Allen & Company, Baillie Gifford and Casdin Capital. In addition to the funding, Daniel O’Day, chief operating officer at Roche Pharmaceuticals, has been added to Flatiron's board of directors.
7 January 2016•4 mins read
